Edition:
India

Aldeyra Therapeutics Reports FY2018 Financial Results


Friday, 8 Mar 2019 

March 8 (Reuters) - Aldeyra Therapeutics Inc ::ALDEYRA THERAPEUTICS ANNOUNCES YEAR-END 2018 FINANCIAL RESULTS.ALDEYRA THERAPEUTICS INC - RESULTS FROM ALLEVIATE PHASE 3 CLINICAL TRIAL IN ALLERGIC CONJUNCTIVITIS EXPECTED IN EARLY 2019.ALDEYRA THERAPEUTICS INC - OPERATIONS EXPECTED TO BE FUNDED THROUGH 2020.ALDEYRA THERAPEUTICS INC - RENEW ADAPTIVE PHASE 3 CLINICAL TRIAL IN DRY EYE DISEASE EXPECTED TO BEGIN IN FIRST HALF OF 2019.ALDEYRA THERAPEUTICS INC - RESULTS FROM SOLACE PHASE 3 CLINICAL TRIAL IN NONINFECTIOUS ANTERIOR UVEITIS EXPECTED IN SECOND HALF OF 2019.ALDEYRA THERAPEUTICS INC - ADAPTIVE PHASE 3 CLINICAL TRIAL OF ADX-2191 IN PROLIFERATIVE VITREORETINOPATHY EXPECTED TO BEGIN IN SECOND HALF OF 2019.